Flex Pharma Shares Plunge After Biotech Ends 2 Clinical Trials, Announces 60% Workforce Cut

Aronora has secured $25 million in grants but is seeking a partner to take its drug candidates into Phase 3 clinical trials......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Cassava Sciences Inc (NASDAQ: SAVA) shares have tumbled to their lowest level since mid-December 2019 after the company issued an adverse clinical readout. read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Gilead Sciences shares surged Friday morning following a media report detailing encouraging partial data from trials of the biotech company's experimental drug remdesivir in severe COVID-19 patients. Fred Katayama reports......»»

Shares of nano-cap biotech Aikido Pharma Inc (NASDAQ: AIKI), are ripping higher following an announcement concerning worldwide licensing of an antiviral platform. read more.....»»

BioNTech SE (NASDAQ: BNTX) shares are trading higher on Thursday, after the company said it would partner with Pfizer (NYSE: PFE) to initiate first clinical trials of the coronavirus vaccine as early as this month. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Dr.Reddy's Laboratories Ltd (NY.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) read more.....»»

Shares of Novavax Inc. jumped 9% in premarket trading on Wednesday after the company said it had identified a COVID-19 vaccine candidate. There are no approved vaccines for the novel coronavirus. Novavax said it plans to begin Phase 1 clinical trials in .....»»

InflaRx shares jumped early on Wednesday after the company announced that it has enrolled its first patient into a clinical trial for the treatment of severe COVID-19-induced pneumonia......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Carnival Corp (NYSE: CCL) shares were trading lower Tuesday after the company announced debt and stock offerings and said it sees preliminary first-quarter EPS of 22 cents per share. read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Vir Biotechnology Inc. teamed with WuXi Biologics and Biogen Inc. to rush a potential treatment for COVID-19 patients into clinical trials, possibly as soon as June. San Francisco-based Vir (NASDAQ: VIR) said early Wednesday that its potential ant.....»»

Shares of small-cap Milestone Pharmaceuticals Inc (NASDAQ: MIST) were losing three-quarters of their value Tuesday on the back of a negative clinical readout. read more.....»»

Shares of Eli Lilly and Co. were down 2% in trading on Monday. The drugmaker has announced Monday morning that it will delay the start of most new clinical studies and is pausing enrollment of participants in ongoing trials due to the COVID-19 p.....»»

The Houston company's drug candidate has shown promising results in combatting MERS and SARS in mice in pre-clinical trials......»»

Shares of several pharma and biotech companies are up sharply over the past monthRelated Stocks: REGN, MRNA, INO, GILD, ABBV, RHHBY, TMO, JNJ, BTNX, PFE, VIR,.....»»